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Since 2000 several papers have examined the efficiency of healthcare delivery systems worldwide. These papers
have extended the literature using drastically different input and output combinations from one another, with little
theoretical or empirical support backing these specifications. Issues arise that many of these inputs and outputs are
available for a subset of OECD countries each year. Using a common estimator and the different specifications
proposed leads to the result that efficiency rankings across papers can diverge quite significantly, with several
countries being highly efficient in one specification and highly inefficient in another. Broad input-output measures
that are collected annually provide consistent efficiency rankings across specifications, compared to specifications
that utilize specific measures collected infrequently. This paper also finds that broad output measures that are not
quality-adjusted, such as life expectancy, seem to be a suitable alternative for infrequently collected quality-adjusted
output measures, such as disability adjusted life years.
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Background and literature review
Since the beginning of 2000, a vast literature on cross-
country healthcare efficiency comparisons has come into
being. Evans et al. [7] and Tandon et al. [24] were the
first to utilize parametric estimators and novel health-
care indicators to identify which country healthcare
delivery systems were most efficient. Since then, a
number of authors have attempted different input-
output specifications, using newer parametric and non-
parametric estimators, to improve upon the original
rankings found in Evans et al. [7] and Tandon et al. [24],
and to attempt to guide policy, including on occasion to
construct healthcare indices from these rankings.
However, a number of issues with the cross-country
healthcare efficiency rankings literature have come into
focus. Critics attacked Evans et al. [7] and Tandon et
al. [24] on their choice of methodology, the output
measures selected by the World Health Organization
(WHO), the weights assigned to output measures,
assumptions made by researchers collecting the data,
and the choice to include Organization for Economic
Cooperation and Development (OECD) countries
along with non-OECD countries in the sample ([10];
[12]; [16, 27]). Gearhart [8] also noted that there was
little correlation between efficiency rankings in the
original Evans et al. [7] and Tandon et al. [24] papers
and his paper, where he utilized the same input and
output measures, but a different, non-parametric,
estimator.
This signifies that the literature suffers from a variety
of limitations, from methodology, to the choice of esti-
mators, to a lack of data, even in the developed world.
An even more disturbing trend is the fact that many of
these efficiency ranking studies are run with little theor-
etical backing for the inputs and outputs that the au-
thors choose to use [1, 2, 4, 9, 11, 22, 23]. The efficiency
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estimations require inputs and outputs to be chosen, as
the healthcare production process turns these inputs
into outputs, which allow for efficiency rankings to be
inferred. Unfortunately, many of the follow-up papers
use rather ad hoc procedures to determine which inputs
and outputs should be used. Little has been done to ei-
ther empirically or theoretically identify which inputs
and outputs should be specified as the most important
when determining the healthcare production process.
Each of these papers have compelling theoretical
reasons for why the individual inputs and outputs
should be used, as each impacts health in a different
way. However, the authors fail to make a compelling
argument as to why these inputs and outputs should be
used cohesively, or why they are strict improvements over
the efficiency rankings provided in other papers that
follow the original WHO studies [7, 8, 10, 12, 16, 24].
As shown in Table 1, since 2005 there have been 9 studies
that, at some point, look at efficiency rankings of countries.
Of these 9 studies, there are 8 different specifications. Only
Gearhart [8] uses a similar specification to that created by
the WHO in 2000, though he uses life expectancy rather
than a created measure by the WHO, disability adjusted life
expectancy (DALE). Another drawback is that, because of
differences in collection procedures across countries, not all
measures are measured each year. Thus, it may be hard to
analyze efficiency changes across years, or analyze product-
ivity improvements (or regression), as some measures are
only collected by decade.
In fact, these issues have led to a number of authors
theorizing that second-stage estimation procedures are
necessary to derive any inference from the many efficiency
rankings studies. These second-stage estimation procedures
would regress the efficiency rankings on environmental
variables that impact health but that are largely outside of
the control of healthcare authorities. Simar and Wilson
[21], however, note that most of these second-stage regres-
sion papers ignore sizable theoretical issues with interpret-
ing the results. They also note that standard ordinary least
squares (OLS) estimates are only appropriate with ex-
tremely restrictive assumptions, and that bootstrapping is
the only method to derive inference consistently.
This paper attempts to shed light on the problems
inherent in the cross-country healthcare efficiency
literature. It attempts to answer the question if there is
considerable variation among efficiency rankings from
the many input-output specifications provided by the 9
papers listed in Table 1. With different measures being
utilized, there can be little consensus and little policy
improvement in this sphere. It also asks whether the
broad measures of healthcare efficiency (some measure of
life expectancy, early age mortality, per capita healthcare
spending, and total educational attainment) provide effi-
ciency rankings that are more consistent across different
specifications than the efficiency rankings found in more
specific measures (healthcare utilization, population com-
position, composition (i.e., public or private) of healthcare
spending). This would highlight the notion that many of
the specifications from other studies including these more
specific measures should use their measures in a second-
stage estimation procedure, where these variables should
be used as environmental variables. Not only may these
broader measures be more appropriate, they are more
likely to be collected on a consistent basis.
This paper finds that the lack of a theoretical input-
output combination can lead to highly divergent effi-
ciency rankings across specifications, and that if these
specifications are being used to guide policy, policy-
makers can specification search for their preferred find-
ing. In fact, this highlights the difficulty in using any of
the literature in any policy-making manner.
This paper finds that efficiency studies that utilize the
broad measures only ([8]; [9]; [22, 23]) have efficiency rank-
ings that are strongly positively correlated with each other,
and that studies that utilize alternative and more specific
input and output measures have efficiency rankings that are
weakly positively correlated (and sometimes negatively
correlated) with each other. This shows the fact that other,
important, socio-economic, quality, and demographic vari-
ables should be used in a second stage regression as envir-
onmental variables. It also finds that quality-adjusted output
measures lead to efficiency rankings that are strongly
positively correlated with efficiency rankings derived from
output measures that do not include healthcare quality.
The paper is organized as follows: Section II details
the data and estimators used, Section III reports the
results, and Section IV concludes.
Data and estimators
Data
Data for this paper comes from the OECD Health Statistics
database, as well as OECD statistics database. All available
measures were calculated for the 30 OECD countries from
2000 to 2012. If data were not available for that year for a
country, that country was indicated as having a missing
value for that measure. All measures were altered by the
author to conform with the data alterations conducted by
the original papers. The data is available in Excel form upon
request from the author. The variables used in the analysis
for this paper are summarized in Table 1.
Output quality measures
The original efficiency literature, utilizing cross-country
comparisons, by Evans et al. [7] and Tandon et al. [24],
attempted to incorporate output quality in a number of
ways. The OECD has, at times, created a number of mea-
sures, such as disability-adjusted life expectancy (DALE),
quality-adjusted life years (QALY), or disability adjusted life
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years (DALY) to take into account differences in the
quality of outcomes. Alternatively, the Evans et al. [7] and
Tandon et al. [24] studies attempted to mitigate the quality
issues by creating a comprehensive output measure
(termed COMP) that weighted different health goals, such
as timeliness of care, differently.
Table 1 Description of previous papers and the input-output combinations used




Adams et al. (2011) [1] 1. Public Spending on Healthcare,
% of GDP
1. Transformed Infant Survival Rate
(ISR), where ISR is the inverse of
the infant mortality rate (IMR),
multiplied by the ratio of public
spending to total spending on
healthcare, both as a % of GDP
2. Transformed Life Expectancy
(LE), where life expectancy is
multiplied by the ratio of public
spending to total spending on
healthcare, both as a % of GDP




Afonso & St. Aubyn
(2005) [2]
1. Inpatient Beds per 1000
population
2. Number of practicing physicians
per 1000 population
3. Number of nurses per 1000
population
1. LE
2. Transformed ISR, where ISR is
1000 minus the IMR, which is






Bhat (2005) [4] 1. Inpatient Beds per 1000 population
2. Number of practicing physicians
per 1000 population
3. Per Capita Pharmaceutical
Expenditures
1. Percent of Population Aged
0–19 Years
2. Percent of Population Aged
20–65 Years
3. Percent of Population Aged
65+
Input-oriented DEA 24 OECD
countries
1996
Gearhart (2016) [8] 1. Per Capita Healthcare Expenditures,
$US Purchasing Power Parity
2. Educational Attainment (Years)
1. LE








González et al. (2010) [9] 1. Per Capita Healthcare Expenditures,
$US Purchasing Power Parity
2. School Life Expectancy (Years)
1. Healthy LE









Grosskopf et al. (2006)
[11]
1. Public Healthcare Expenditures,
% of per Capita GDP
2. Private Healthcare Expenditures,
% of per Capita GDP
3. Per Capita Gross Capital Formation
4. Per Capita Labor Force
5. Primary Education Enrollment Rate
1. LE
2. Under-5 survival rate (U5SR),
where U5SR is the inverse of the
childhood mortality rate (CMR)
3. Per Capita GDP
Output-oriented DEA 143 countries 1997
Kim and Kang (2014) [13] 1. Average Years of Schooling,
Women Aged 15+
2. Public Healthcare Expenditures,
% of government expenditure on
health care in 2007 U.S. dollars
1. LE
2. Under-5 survival rate (U5SR),
where U5SR is the inverse of the
childhood mortality rate (CMR)






1. School Life Expectancy (Years)
2. Gini Coefficient
3. Tobacco Use (Maximum of the
percent of Male or Female Smokers)
4. Practicing Physicians per 1000
Population
5. Inpatient Beds per 1000 Population
6. MRI Units per 1,000,000 Population
7. Per Capita Healthcare Expenditures
as Fraction of Per Capita GDP,
$US Purchasing Power Parity
1. Life Expectancy







(2005, 2009) [22, 23]
1. School Life Expectancy (Years)
2. Unemployment Rate
3. Per Capita GDP
4. Per Capita Healthcare Expenditures,
$US Purchasing Power Parity
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Unfortunately, these quality-adjusted output measures
are not as robust as they need to be when conducting ef-
ficiency analysis. Williams [27] and Richardson et al.
[16] detailed the quite significant issues with the arbi-
trary weighting schemes utilized by Evans et al. [7] and
Tandon et al. [24] when creating their COMP output
measure. Hollingsworth and Wildman [12] noted that
these quality output measures are often self-reported
measures or utility measures (QALY). They noted that
these measures are not used often because they are not
routinely collected by various agencies, are subject to
large variations in methodological rigor between coun-
tries, and are open to interpretation, which may violate
the homogeneity assumption utilized by non-parametric
frontier estimators.
Gearhart [8] noted that efficiency results were similar
when utilizing DALY or life expectancy, so for methodo-
logical simplicity, life expectancy was chosen as the
output measure. In this paper, quality measures are ex-
plicitly considered by two papers: (1) Adams et al. [1],
where they modify infant survival rates and life expect-
ancy by the ratio of the public spending on healthcare to
total spending on healthcare (both as a percent of GDP),
and (2) González et al. [9], who utilize both healthy life
expectancy and DALY as their output measures. The rest
of the papers summarized use unconditional output
measures that do not take quality into account. The
results of the relationship between papers with and with-
out modified quality output measures will be discussed
in the Results and Discussion section.
Methods
Limitations and benefits of different non-parametric
estimators
Table 1 summarizes the estimators utilized by the 9 dif-
ferent papers under investigation. All papers in the
sample utilize non-parametric estimators, rather than
parametric estimators. Most of the papers utilize non-
parametric data envelopment analysis (DEA) estimators.
Only one paper [8] utilizes the order-α estimator that will
be utilized to estimate all efficiency results in this paper.
In this section, I describe the benefits of using non-
parametric estimators in general, as well as the limitations
of using the DEA estimators. I then describe why the
order-α estimator seems to be superior, and then describe
the calculations undertaken by the order-α estimator.
Non-parametric estimators are often used by re-
searchers because they do not require an a priori specifi-
cation of the functional relationship that is being
estimated. Similarly, because of the lack of distributional
assumption, incorporating multiple inputs or outputs is
seamless. However, the DEA estimator used by many
researchers suffers from well-known problems that make
validity and inference a problem. The problems include
the DEA estimator having less than root-n convergence
due to the curse of dimensionality, where the number of
observations required to obtain meaningful estimates
increases with the number of production inputs and out-
puts used in the estimation; it also includes the estima-
tor being sensitive to outliers [14]. The DEA estimator
also, by construction, leads to many units in the analysis
Table 2 Countries with missing observations in 2000 or 2012, 9 cross-country healthcare comparison studies
Author 2000 countries missing 2012 countries missing
Adams et al. (2011) [1] Hungary, South Korea, Mexico, Turkey Canada, Chile, Hungary, Mexico, New Zealand, Turkey
Afonso & St. Aubyn (2005) [2] Belgium, Chile, Iceland, Ireland, Italy, Japan,
South Korea, Luxembourg, New Zealand,
Norway, Poland, Portugal, Switzerland
Denmark, Finland, Germany, Greece, Netherlands,
New Zealand, Sweden, Switzerland
Bhat (2005) [4] Belgium, Chile, Hungary, Iceland, Ireland,
Israel, Italy, Luxembourg, Mexico,
New Zealand, Poland, Slovenia, Switzerland,
Turkey
Australia, Canada, Denmark, Greece, Hungary, Israel,
Japan, Mexico, Netherlands, New Zealand, Portugal,
Turkey, United Kingdom
Gearhart (2016) [8] South Korea Australia, Canada, Chile, New Zealand
González et al. (2010) [9] Norway Australia, New Zealand, Norway
Grosskopf et al. (2006) [11] Austria, Chile, Czech Republic, Hungary,
Mexico, Slovakia, Turkey
Austria, Canada, Czech Republic, Greece, Hungary,
Iceland, Israel, Italy, Luxembourg, Mexico, Slovakia,
Turkey
Kim and Kang (2014) [13] Hungary, Mexico, Turkey All OECD Countries
Retzlaff-Roberts et al. (2004) [15] Australia, Austria, Belgium, Canada, Chile,
Czech Republic, Estonia, Germany, Greece,
Iceland, Ireland, Italy, Japan, South Korea,
Mexico, Netherlands, New Zealand, Norway,
Portugal, Slovakia, Slovenia, Spain, Sweden,
Switzerland, Turkey, United States
Australia, Austria, Belgium, Canada, Chile, Denmark,
Germany, Greece, Hungary, Ireland, Luxembourg,
Netherlands, New Zealand, Norway, Poland, Portugal,
Slovakia, Spain, Sweden, United Kingdom
Spinks and Hollingsworth (2005, 2009) [22, 23] Hungary, Mexico, Turkey Hungary, Mexico, New Zealand, Turkey
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being considered fully efficient, as it is a full frontier esti-
mator [20].
Alternatives to DEA estimators, such as the order- α
estimator (which involves estimating a partial frontier
lying “close” to the true production frontier), have been
developed which alleviate many of these problems.1 Un-
like the DEA estimator, the order-α estimator is robust
to outliers. The order- α estimator is a partial frontier
estimator, and it allows some observations to lie above
the estimated partial frontier, limiting the impacts of
extreme values (or outliers) on efficiency scores [20]. By
design, this also limits the number of units that are
deemed as fully efficient. The order-α estimator also
addresses the curse of dimensionality found in DEA
estimators; by design, the order-α estimator achieves the
classical, parametric root- n rate of convergence, even
though it is a fully non-parametric estimator [26]. The
hyperbolic order-α estimator thus provides the distribu-
tional flexibility of non-parametric estimators while
simultaneously providing traditional statistical features
found in parametric estimators.2
Hyperbolic order-α estimator methodology
Unfortunately, having to choose between an input-
orientation (holding outputs fixed, can a country reduce
healthcare inputs) and an output-orientation (holding
inputs fixed, can a country increase healthcare outputs)
leads to an issue surrounding the order- α estimator as
well as the DEA estimator. In fact, Spinks and Hollings-
worth [23] note that utilizing the input-orientation may
not make sense for many health measures. As noted in
Wheelock and Wilson [26], the choice between input-
or output-orientation is often arbitrary. Wheelock and
Wilson [25] offer a way out the choice between the
input-orientation and the output-orientation. They
describe an unconditional hyperbolic order- α quantile
estimator that shares the advantages of the estimators
described in Aragon et al. [3] and Daouia and Simar [5],
but which avoids the third problem of choosing the
orientation of the estimator. Since this paper is outside
the context of a regression framework, the choice of
direction function (input, output, or hyperbolic) does
not have behavioral implications as it does in regression
analysis; the hyperbolic distance function is therefore
used. This allows for input contraction at a given output
level, output expansion at a given input level, or a com-
bination of input contraction and output expansion.
Due to this, the hyperbolic order- α estimator is uti-
lized, which is a partial frontier estimator. The order-α
estimator was developed a potential solution to the
known problems in other non-parametric estimators
described above, and where α ∈ (0,1] corresponds to the
level of an appropriate non-standard conditional quan-
tile frontier. The choice of α is continuous on the
interval (0,1]. Wheelock and Wilson [25] define the
hyperbolic order-α estimator as
γα x; yð Þ ¼ sup γ > 0 H γ−1x; γy
 
> 1−αð Þ  ð1Þ
using the Shephard [17] metric, where H x; yð Þ ¼ Pr
X≤x;Y≥yð Þ , which represents the probability that a
unit operating at (x, y) is dominated (producing more
output with the same level of inputs; producing the
same level of output with less inputs; or producing
more outputs using less inputs). H (x, y) is estimated
by bH x; yð Þ ¼ Xn
i¼1
I Xi≤x;Y i≥yð Þ
n
 
, where I ⋅ð Þ repre-
sents the indicator function. γα is estimated by
bγα x; yð Þ ¼ supfγ > 0jbH γ−1x; γy  > 1−αð Þg ð2Þ
Wheelock and Wilson [25] establish the consistency of
the hyperbolic order-α estimator.
Table 3 Cross-country efficiency rankings in 2010 for 23
countries using common hyperbolic order-α estimator








Austria 22 23 14 6
Belgium 13 16 15 15
Canada 7 4 22 19
Czech
Republic
17 18 9 21
Estonia 10 5 1 17
Finland 15 13 12 4
France 18 17 16 10
Germany 20 15 21 18
Iceland 12 14 10 2
Israel 8 2 5 5
Japan 4 3 8 11
Korea 1 9 6 12
Luxembourg 9 11 17 3
New Zealand 14 1 18 20
Norway 23 12 20 14
Poland 2 6 2 8
Portugal 3 20 3 1
Slovak
Republic
19 21 11 23
Slovenia 5 7 7 7
Spain 11 19 4 9
Sweden 6 8 19 13
Switzerland 21 22 13 16
US 16 10 23 22
This is estimated for the year 2010. These are the efficiency rankings, by
country, in 2010, using the hyperbolic order-α estimator
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If γα x; yð Þ ¼ 1, the point is said to lie on the hyperbolic
order-α quantile and is dominated by firms with a prob-
ability of (1−α) [20]. Another useful feature of the order-




An assumption used by non-parametric estimators is
that the units being considered are homogeneous (also
known as independence). A number of authors that have
undergone cross-country efficiency analysis have noted
that OECD countries are suitably homogeneous to
employ non-parametric efficiency estimation models
[8, 10, 12]. In his paper, Greene [10] notes that al-
most all of the inefficiency noise in his study comes
from non-OECD countries. Kim and Kang [13] utilize
World Bank income groups to stratify their countries to
satisfy the homogeneity assumption for the DEA estima-
tor: importantly, all the OECD countries fall into the same
World Bank income group, “high income”.
Simar and Wilson [18] note that the assumption of
homogeneous units, in non-parametric efficiency ana-
lysis, is reasonable in many situations. Simar and Wilson
[19], however, described a heterogeneous bootstrapping
procedure that does not utilize the assumption of homo-
geneity, though it comes at the cost of increased compu-
tational length. Wilson [28] notes a variety of simple,
non-parametric tests for independence that occurs
before efficiency analysis needs to be taken place. Using
several of the tests proposed in Wilson [28], this paper
fails to reject the null hypothesis of homogeneity.3 The
analysis therefore utilizes the assumption that OECD
countries are suitably homogeneous.
Sampling difficulties
One issue that arises with the various specifications
chosen by the various papers is that many of the vari-
ables chosen are not collected regularly by the OECD
or the countries themselves. Table 2 shows that, in
2000 and 2012, only a handful of countries have data
for all of the specifications provided by all 9 papers.4, 5 In
fact, in 2000, only 4 countries are common between
all 9 papers: Denmark, Finland, France, and the
United Kingdom.
In one case, school life-expectancy and healthy life
expectancy, utilized by González et al. [9], are measured
in 2000 and 2012 only. Some authors have attempted
data interpolation [8, 10, 15], but this comes with its
own caveats. This supports one of the main findings of
the paper: that broad, regularly collected input and out-
put measures (some measure of life expectancy, early
age mortality, total education, and per capita healthcare
spending) should be utilized, rather than specific mea-
sures that are collected sporadically.
As can be seen from Table 2, the papers with the
broadest input-output measures [8, 9, 22, 23] share 29
out of the 34 OECD countries in common in 2000, while
sharing 26 out of the 34 OECD countries in common
in 2012.
Fig. 1 Cross-country efficiency ranking comparisons and Pearson correlation coefficients using hyperbolic order-α estimator, 2010. *NOTE: This
figure compares cross-country efficiency rankings across a variety of paper specifications. Numbers in the upper triangle represent the Pearson
correlation coefficient between any two sets of rankings
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Efficiency results and discussion
A first finding is that because of the lack of a theoretic-
ally justified input-output combination, there exists quite
considerable variation in country efficiency rankings
across specifications. Table 3 presents efficiency rankings
from the following 4 papers: (1) Afonso and St. Aubyn [2];
(2) Bhat [4]; (3) Gearhart [8]; and (4) Kim and Kang [13].
In 2010, only 23 countries have observations for all 4
of these papers.6 The first result becomes apparent: The
U.S., which has been deemed to have one of the most in-
efficient healthcare delivery systems in the world [7, 8]
ranks anywhere from 10th (middle of the pack) to 23rd
(dead last). Other countries, such as South Korea and
New Zealand, exhibit a high degree of variability in their
rankings as well.
These efficiency rankings are an improvement on the
rankings found in the original papers. In Afonso and St.
Aubyn [2], 8 out of the 23 countries tie for being the
most efficient producers of healthcare; these include
Canada, Japan, the United States, Spain, and Sweden. In
this study, as can be seen in Table 3, the highest ranking
of any of these countries is 4th (Japan) and 6th
(Sweden). In fact, there is only a mild positive correl-
ation between the rankings found in this paper and
those in Afonso and St. Aubyn [2], with a Pearson
correlation coefficient of 0.32. There is a negative correl-
ation between the rankings found in this paper and
those in Bhat [4].7
These highlight the two methodological issues in
Afonso and St. Aubyn [2] and Bhat [4], among others that

















Australia 15 22 13 18 23 12 19 22
Belgium 14 15 22 14 25 18 14 16
Canada 20 23 14 16 20 19 15 18
Denmark 19 24 25 19 14 20 23 21
Estonia 6 1 1 24 1 1 2 2
Finland 3 8 15 1 24 4 18 9
France 21 16 16 12 22 22 20 23
Germany 22 17 17 17 19 23 22 24
Greece 16 4 4 3 12 17 8 11
Iceland 10 11 10 7 6 7 24 17
Ireland 5 20 21 23 10 2 4 4
Israel 11 10 9 6 15 10 6 8
Italy 12 9 8 4 21 15 10 13
Japan 1 7 3 11 8 8 16 12
Luxembourg 8 21 6 9 5 3 3 3
Netherlands 17 18 23 10 3 13 13 15
New
Zealand
13 12 18 22 11 16 5 6
Poland 2 2 2 8 2 5 1 1
Portugal 23 3 12 5 4 24 25 25
Slovenia 18 6 7 20 7 21 9 7
Spain 4 5 5 13 16 11 17 20
Sweden 7 13 19 2 17 6 12 5
Switzerland 24 19 11 15 9 14 21 19
UK 9 14 20 21 13 9 7 10
US 25 25 24 25 18 25 11 14
This is estimated for the year 2000. These are the efficiency rankings, by country, in 2000, estimated using the hyperbolic order-α estimator
aGrosskopf et al. [11] refers to utilizing, as inputs, public healthcare expenditures and private healthcare expenditures, both as a percent of per capita GDP
bGrosskopf et al. [11] refers to utilizing, as inputs, public healthcare expenditures and private healthcare expenditures, both as a percent of per capita GDP; the
per capita labor force; and per capita gross capital formation
cGrosskopf et al. [11] refers to utilizing, as inputs, public healthcare expenditures and private healthcare expenditures, both as a percent of per capita GDP; the per
capita labor force; per capita gross capital formation; and the primary education enrollment rate
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use DEA, that are rectified using the order- ∝ estimator:
(1) the use of a DEA estimator with few observations and
many variables, and (2) potential incorrect specifications
as to what a healthcare delivery system should focus on.
Figure 1 crosswise plots efficiency rankings from the 4
specifications in Table 3 with a line of best fit, as well as
reporting the crosswise correlations between the papers.
Afonso and St. Aubyn [2] have positive correlations with
all other papers, ranging from 0.38 to 0.56. Most strik-
ing, however, is the fact that Bhat [4] varies significantly
in how it correlates to the other papers. It has almost no
correlation with Gearhart [8]. Bhat [4] is even slightly
negative correlated with Kim and Kang [13], with a
Pearson correlation coefficient of −0.06. This highlights
the fact that even looking at a small number of studies
that attempt to measure healthcare efficiency can lead to
highly divergent efficiency rankings. One paper can find
that a certain country is highly efficient in producing
healthcare while another can find that the same country
is highly inefficient. These findings have been supported
in Gearhart [8].
This means that the lack of theoretical underpinning
of these models can lead to policymaker specification
searching, where by changing the input-output mix, they
can obtain whichever answer they seek.
From Table 2, we note that broad input-output vari-
ables (some measure of life expectancy, early age mortal-
ity, total education, and per capita healthcare spending)
are superior to more specific input-output variables, as
they are collected more frequently, and allow for the
analysis of efficiency gains over longer periods of time.8
This paper now attempts to support this finding from ef-
ficiency analysis, using results from a hyperbolic order-α
estimator.
Table 4 shows results for the specifications provided in
6 papers in 2000.9
Again, we see that across the wide variety of specifica-
tions, there is considerable variation in the efficiency
rankings. For instance, Finland ranks anywhere from 1st
(most efficient) to 24th (second most inefficient) out of
25 countries. Similar variability can be seen in the U.S.,
which rankings 11th to 25th. Note, however, that the
rankings provided by the papers that utilize broad input-
output measures [8, 9, 22, 23] seem to be much more
consistent with each other than the rankings from the
other papers, which utilize more specific input-output
variables. Note that the broad input-output measures are
ones that have some measure of life expectancy, some
measure of early age mortality, some measure of total
education, and some measure of per capita healthcare
spending. These are measured consistently across coun-
tries and collected most years, and are able to capture
the individual impacts on the whole population. More
specific measures include the composition of spending
(whether it is public or private), healthcare utilization
(number of doctors, nurses, and beds per capita), and
population composition.10 These measures are not
collected consistently, and are better utilized as environ-
mental variables in a second-stage estimation procedure.
This can be seen better in Fig. 2, which plots the pair-
wise efficiency rankings and correlation coefficients from
the papers found in Table 4.
Fig. 2 Cross-country efficiency ranking comparisons and Pearson correlation coefficients using hyperbolic order-α estimator, 2000. *NOTE: This
figure compares cross-country efficiency rankings across a variety of paper specifications. Numbers in the upper triangle represent the Pearson
correlation coefficient between any two sets of rankings
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In general, there is a positive correlation between most
of the rankings in all of the papers. The average correl-
ation is weakly positive, 0.36 (the median correlation be-
ing 0.34). However, nearly two-thirds of the correlations
are less than 0.4 (weakly positive), while almost 10 % of
the correlations are negative. The 3 papers that utilize
the broad input-output measures [8, 9, 22, 23] have
Pearson correlation coefficients that are higher, when
compared to one another, than the other specifications
that use more specific measures. The average Pearson
correlation coefficient between the papers that utilize
the broad measures [8, 9, 22, 23] is slightly above 0.5,
while the average for the rest of the specifications is
slightly less than 0.3.
Not only are the broad measures collected more con-
sistently (and allow for more testing), but they are more
consistent across different specifications. This allows a
bit of freedom for researchers to modify these measures,
without changing much of the underlying efficiency
structure. The fact that the specifications with more spe-
cific input-output variables lead to highly variable effi-
ciency rankings also indicates an important point: these
variables should be used as environmental variables in a
second-stage estimation procedure, as they play an im-
portant role in influencing the effectiveness of health-
care, but may be largely outside of the control of
policymakers, and may be related to structural features
of a country.
Table 5 presents efficiency rankings, in 2012, from 4
studies: (1) Adams et al. [1]; Gearhart (2) [8]; (3) González
[9]; and (4) Spinks and Hollingsworth [22, 23].
Adam et al. is similar to the latter 3 studies that utilize
the broad measures of healthcare, but differs in a par-
ticular matter; it uses the composition of healthcare
spending spending (public spending on healthcare as a
percent of GDP) as an input, rather than per capita
healthcare spending. This introduces difficulties into the
estimation, as noted by Dyson et al. [6] and Gearhart
[8]. This can be seen in Fig. 3, which pairwise compares
efficiency rankings (as well as providing the Pearson
correlation coefficient) between the rankings from the
4 studies.
As can be seen, the introduction of the composition of
healthcare spending, rather than per capita healthcare
spending, means that the efficiency rankings utilizing the
specification from Adams et al. [1] are less consistent than
the specifications in the other 3 specifications. This again
supports the findings in Dyson et al. [6] and Gearhart [8]
that including the composition of spending on healthcare
can influence the results by perhaps eliminating the homo-
geneity of the countries under observation. This supports
again the main findings: that broad measures of healthcare
should be used as input-output variables, rather than more
specific measures. Instead, these specific measures, because
they do influence efficiency rankings quite considerably
(when looking at the considerable variation in efficiency
rankings, as seen in Fig. 2) should be utilized as environ-
mental variables in a second-stage estimation procedure.
Figure 3 also highlights another main result in this
paper: that utilizing more consistently collected output
measures that do not adjust for healthcare quality (at the
country level) seem to provide results that are highly
consistent with those that use quality-adjusted output
measures. Gearhart [8] uses life expectancy and infant
survival rates, both of which do not take into account
quality. González et al. [9], however, utilized healthy life
expectancy and DALY as their output measures, both
collected as a way to measure quality of a healthcare
system at the country level. These two papers utilize the
same input combination, allowing us to analyze whether
Table 5 Cross-country efficiency rankings in 2012 for 26
















Austria 25 18 18 9
Belgium 23 22 21 21
Czech Republic 7 9 4 5
Denmark 12 24 26 25
Estonia 3 1 1 2
Finland 13 14 22 22
France 21 19 12 19
Germany 22 21 23 16
Greece 11 4 13 13
Iceland 1 11 14 15
Ireland 10 20 19 24
Israel 6 7 3 10
Italy 14 10 10 11
Japan 8 12 7 4
Korea 5 6 5 1
Luxembourg 4 15 8 7
Netherlands 20 25 24 23
Poland 9 2 2 3
Portugal 15 3 15 12
Slovakia 16 8 6 8
Slovenia 2 13 20 6
Spain 19 5 9 17
Sweden 17 16 17 20
Switzerland 24 17 16 18
UK 18 23 11 14
US 26 26 25 26
This is estimated for the year 2012. These are the efficiency rankings, by
country, in 2012, estimated using the hyperbolic order-α estimator
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the efficiency ranking results are highly different. As can
be seen in Fig. 3, the Pearson correlation coefficient
between the rankings using the specification in Gearhart
[8] and González et al. [9] is highly positive, at 0.76.
Comparing González et al. [9] to Spinks and Hollings-
worth [22, 23], the correlation is 0.8.
This highlights that non-quality adjusted output measures
seem to be an adequate substitute for quality-adjusted
output measures that are collected infrequently (as
mentioned earlier, healthy life expectancy has been mea-
sured for 2000 and 2012 only). Fortunately, health agencies
across the world are taking note of the need to create
quality-adjusted output measures to properly account for
heterogeneity in patient populations. This means that the
utilization of quality-adjusted output measures should be
more standard in the future.
Conclusion
It has been shown that there are considerable limitations
with the variety of specifications utilized in cross-
country healthcare efficiency comparisons since 2005. In
a total of 9 studies replicated in this paper, there have
been 8 unique specifications. One problem includes the
fact that it is impossible to crosswise compare all
specifications for any year between 2000 and 2012, due
to many variables being collected infrequently. When
able to compare certain specifications with one another,
there is considerable deviation between efficiency rank-
ings across specifications; in general, there is only a
mildly positive correlation between specification effi-
ciency rankings.
This indicates that utilizing broad measures is the
appropriate procedure for healthcare efficiency rankings.
These variables (some measure of life expectancy, early
age mortality, total education, and per capita healthcare
spending) are collected consistently. As shown in Using
specific healthcare measures and the resulting variability
in efficiency rankings hints that they are inappropriate
for efficiency rankings directly, but should instead be
utilized as socio-economic, quality, and demographic
environmental variables in secondary regressions.
This means that there is considerable opportunity for
specification searching on the part of researchers and
policymakers. Policymakers can choose which input and
output combinations yield the results (either highly effi-
cient or highly inefficient) they desire.
A second limitation is that though these studies can
conceivably be reconciled using a two-stage regression
framework, where many of the variables used in studies
(such as per capita labor force and the fraction of the
population that is over the age of 65) could be used as en-
vironmental variables, there are limitations on which tech-
niques can be used, which may require more consistent
data than is available to allow for bootstrapping. Though
these issues can be overcome, it does hint that papers
studying this problem should be scrutinized severely.
Further research should focus on utilizing a second-stage
regression framework to incorporate some of the
alternative inputs as environmental variables. This may
allow researchers to determine the outside factors that
impact efficiency estimates and may resolve the dispute
between which measures should be included in an
Fig. 3 Cross-country efficiency ranking comparisons and Pearson correlation coefficients using hyperbolic order-α estimator, 2012. *NOTE: This
figure compares cross-country efficiency rankings across a variety of paper specifications. Numbers in the upper triangle represent the Pearson
correlation coefficient between any two sets of rankings
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efficiency analysis. Additional research should also continue
to develop a theoretical underpinning for which input-
output combinations are desirable, though this may change
over time. This backing should take into consideration data
limitations and cross-country collection issues.
Lastly, the fact that output measures that are not
adjusted for quality (life expectancy) are consistent sub-
stitutes for quality-adjusted output measures (DALY,
QALY) means that cross-country analysis can still be
conducted, while the OECD continues to develop, main-
tain, and produce these quality-adjusted output mea-
sures on a more consistent basis. It hints that though
the development of these measures is optimal, they are
not a necessary condition for evaluating healthcare effi-
ciency across countries.
Endnotes
1Aragon et al. [3] and Daouia and Simar [5] estimate
input- and output-oriented conditional quantiles of
order- α.
2These statistical features are a lack of sensitivity to
outliers as well as the root- n convergence rate.
3Results are available upon request from the author.
4Other years in between 2000 and 2010 show similar
results. I utilize 2000 because that year helped to jump
start the cross-country healthcare comparison literature
and 2012 because it is the most comprehensive year with
data on the OECD website.
5In fact, Retzlaff-Roberts et al. [15] have 26 missing
country observations in 2000 and 20 in 2012. Their
specification, for this reason, will not be utilized in this
paper.
6If we were to add 2 additional papers, [11] and [22, 23],
the number of OECD countries that would have observa-
tions across all specifications falls to 17. This is a relatively
unsuitable number of observations for a cross-section.
This results is available upon request from the author.
7These findings are available upon request from the
author.
8This would be done utilizing a Malmquist Index,
which is not utilized in this paper, but can be seen in
others [8].
9Note that Table 4 supports the first finding; across
the wide variety of specifications, there is quite consider-
able efficiency ranking variation.
10The composition of healthcare spending, whether it
is public or private (in terms of GDP or total healthcare
spending), is not mentioned as a “broad” indicator for a
variety of reasons. A main reason is that the compos-
ition of spending has historical and political explanations
that may wrongly influence efficiency estimates. Another
is that the introduction of this variable may call into
question several of the underlying assumptions that
non-parametric efficiency estimators are based on [6].
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